E-LIB Suche - Ergebnisse für: Wadelius, M

1

Identification of risk factors for adverse drug reactions i..:

Attelind, S. ; Eriksson, N. ; Sundström, A...
Pharmacoepidemiology and Drug Safety. 33 (2024) 1 - p. , 2024

Link: https://doi.org/10.1002/..

2

Technological readiness and implementation of genomic‐drive..:

Franks, P. W. ; Melén, E. ; Friedman, M....
Journal of Internal Medicine. 290 (2021) 3 - p. 602-620 , 2021

Link: https://doi.org/10.1111/..

3

Clinical Pharmacogenetics Implementation Consortium (CPIC) ..:

Johnson, JA ; Caudle, KE ; Gong, L...
Clinical Pharmacology & Therapeutics. 102 (2017) 3 - p. 397-404 , 2017

Link: https://doi.org/10.1002/..

4

Regulatory Variants Other Than VKORC1 rs9923231 May Explain..:

Cavalli, M. ; Pan, G. ; Wallerman, O...
Clinical Therapeutics. 39 (2017) 8 - p. e76-e77 , 2017

Link: https://doi.org/10.1016/..

5

Time to onset of bisphosphonate‐related osteonecrosis of th..:

Fung, PPL ; Bedogni, G ; Bedogni, A...
Oral Diseases. 23 (2017) 4 - p. 477-483 , 2017

Link: https://doi.org/10.1111/..

6

Genome-Wide Association Study of Angioedema Induced by Ace ..:

Wadelius, M. ; Eriksson, N. ; Johansson, C....
Clinical Therapeutics. 39 (2017) 8 - p. e76 , 2017

Link: https://doi.org/10.1016/..

7

Cost-effectiveness of pharmacogenetic-guided dosing of warf..:

Verhoef, T I ; Redekop, W K ; Langenskiold, S...
The Pharmacogenomics Journal. 16 (2016) 5 - p. 478-484 , 2016

Link: https://doi.org/10.1038/..

8

Patients Benefit From Genetics-Guided Coumarin Anticoagulan..:

Zee, A H Maitland-van der ; Daly, A K ; Kamali, F...
Clinical Pharmacology & Therapeutics. 96 (2014) 1 - p. 15-17 , 2014

Link: https://doi.org/10.1038/..

9

Phenotype Standardization of Angioedema in the Head and Nec..:

Wadelius, M ; Marshall, S E ; Islander, G...
Clinical Pharmacology & Therapeutics. 96 (2014) 4 - p. 477-481 , 2014

Link: https://doi.org/10.1038/..

10

Phenotype Standardization for Statin-Induced Myotoxicity:

Alfirevic, A ; Neely, D ; Armitage, J...
Clinical Pharmacology & Therapeutics. 96 (2014) 4 - p. 470-476 , 2014

Link: https://doi.org/10.1038/..

11

The Clinical Pharmacogenetics Implementation Consortium Gui..:

Ramsey, L B ; Johnson, S G ; Caudle, K E...
Clinical Pharmacology & Therapeutics. 96 (2014) 4 - p. 423-428 , 2014

Link: https://doi.org/10.1038/..

12

The Clinical Pharmacogenomics Implementation Consortium: CP..:

Wilke, R A ; Ramsey, L B ; Johnson, S G...
Clinical Pharmacology & Therapeutics. 92 (2012) 1 - p. 112-117 , 2012

Link: https://doi.org/10.1038/..

13

Clinical Pharmacogenetics Implementation Consortium Guideli..:

Johnson, J A ; Gong, L ; Whirl-Carrillo, M...
Clinical Pharmacology & Therapeutics. 90 (2011) 4 - p. 625-629 , 2011

Link: https://doi.org/10.1038/..

14

A Proposal for an Individualized Pharmacogenetics-Based War..:

Avery, P J ; Jorgensen, A ; Hamberg, A K...
Clinical Pharmacology & Therapeutics. 90 (2011) 5 - p. 701-706 , 2011

Link: https://doi.org/10.1038/..

15

Integration of Genetic, Clinical, and INR Data to Refine Wa..:

Lenzini, P ; Wadelius, M ; Kimmel, S...
Clinical Pharmacology & Therapeutics. 87 (2010) 5 - p. 572-578 , 2010

Link: https://doi.org/10.1038/..